Nelson J Dusetti

29PUBLICATIONS
245CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTissue engineeringNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Jun 04, 2026
Luminal-basal stratification of the native human pancreatic duct is differentially represented in pancreatic cancers.

|Jun 01, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

|May 11, 2026
ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

|Apr 23, 2026
Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries.

Pageof 5

Frequent Collaborators

14 joint publications

Juan Lucio Iovanna

6 joint publications

Remy Nicolle

4 joint publications

Richard Tomasini

4 joint publications

Jerome Cros